Effects of ghrelin treatment on exertional dyspnea in COPD: an exploratory analysis

被引:0
|
作者
Keisuke Miki
Ryoji Maekura
Noritoshi Nagaya
Mari Miki
Seigo Kitada
Kenji Yoshimura
Masahide Mori
Kenji Kangawa
机构
[1] National Hospital Organization Toneyama National Hospital,Department of Respiratory Medicine
[2] National Cerebral and Cardiovascular Center Research Institute,Department of Regenerative Medicine
[3] National Cerebral and Cardiovascular Center Research Institute,Department of Biochemistry
来源
The Journal of Physiological Sciences | 2015年 / 65卷
关键词
Dyspnea; Exercise; Pulmonary rehabilitation; Lactate threshold; Underweight;
D O I
暂无
中图分类号
学科分类号
摘要
A substudy of ghrelin treatment in a multicenter trial previously revealed that administration of ghrelin improves the exercise capacity of underweight COPD patients. To clarify exertional dyspnea more precisely, exploratory analysis was conducted on data from the substudy. Of 20 underweight COPD patients who were randomized to pulmonary rehabilitation with intravenous ghrelin (2 μg/kg, n = 10) or placebo (n = 10) twice daily for 3 weeks in the substudy, 16 (ghrelin = 9, placebo = 7) could be investigated for dyspnea break-point on the dyspnea-ratio (%) of Δoxygen uptake (V˙O2\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${\dot{V}}_{{\rm O}_{2}}$$\end{document}) (= peak minus resting V˙O2\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${\dot{V}}_{{\rm O}_{2}}$$\end{document}) curve. A significant treatment effect of ghrelin on percentage V˙O2\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${\dot{V}}_{{\rm O}_{2}}$$\end{document} at the dyspnea break-point to ΔV˙O2\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${\dot{V}}_{{\rm O}_{2}}$$\end{document} (p = 0.049) was achieved. In conclusion, underweight COPD patients benefitted from ghrelin treatment in terms of shifts to the early exercise phase of the dyspnea break-point during a standardized exercise program.
引用
收藏
页码:277 / 284
页数:7
相关论文
共 50 条
  • [1] Effects of ghrelin treatment on exertional dyspnea in COPD: an exploratory analysis
    Miki, Keisuke
    Maekura, Ryoji
    Nagaya, Noritoshi
    Miki, Mari
    Kitada, Seigo
    Yoshimura, Kenji
    Mori, Masahide
    Kangawa, Kenji
    Journal of Physiological Sciences, 2015, 65 (03): : 277 - 284
  • [2] Effects of ghrelin on the dyspnea pattern in cachectic COPD: Exploratory analysis of a substudy of a multicenter, randomized, double-blind, placebo-controlled trial of ghrelin treatment
    Miki, Keisuke
    Maekura, Ryoji
    Nagaya, Noritoshi
    Kitada, Seigo
    Miki, Mari
    Yoshimura, Kenji
    Matsui, Hideki
    Satomi, Akitoshi
    Hashimoto, HIsako
    Mori, Masahide
    Kangawa, Kenji
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [3] Optimizing the dyspnea challenge: Measuring exertional dyspnea in COPD
    Aitken, C.
    Walsh, J.
    Sabapathy, S.
    Stewart, G.
    Adams, L.
    Morris, N.
    RESPIROLOGY, 2022, 27 : 69 - 69
  • [4] The examination of two tests measuring exertional dyspnea in COPD
    Palmer, T.
    Obst, S.
    Walsh, J.
    Sabapathy, S.
    Morris, N.
    RESPIROLOGY, 2024, 29 : 240 - 240
  • [5] Descriptors of exertional dyspnea across the COPD severity spectrum
    Webb, Katherine
    O'Donnell, Denis
    Neder, Alberto
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [6] Ventilatory drive at rest and perception of exertional dyspnea in severe COPD
    Marin, JM
    de Oca, MM
    Rassulo, J
    Celli, BR
    CHEST, 1999, 115 (05) : 1293 - 1300
  • [7] Exertional dyspnea in COPD: the dominant role of increased diaphragmatic activation
    James, Matthew
    Milne, Kathryn
    Masthan, Megha Ibrahim
    Neder, J. Alberto
    O'Donnell, Denis
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [8] Correlation between Exertional Dyspnea and Diaphragmatic Capacity in Patients with COPD
    Thomer, J.
    Elfeturi, M.
    Joern, B.
    Wagner, F.
    Pareja, Hidalgo D.
    Yousef, S.
    Gorol, O.
    Ratsimba, F.
    Kuehnel, M.
    Regmi, B.
    Dreher, M.
    Spiesshoefer, J.
    PNEUMOLOGIE, 2024, 78 : S70 - S70
  • [9] EXERTIONAL DYSPNEA: MARATHON TO DIAGNOSIS, SPRINT TO TREATMENT
    Hobocan, Marissa
    Ramirez, Verity
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 2584 - 2584
  • [10] Paced-Walk and Step Tests to Assess Exertional Dyspnea in COPD
    Perrault, Helene
    Baril, Jacinthe
    Henophy, Sara
    Rycroft, Ashley
    Bourbeau, Jean
    Maltais, Francois
    COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2009, 6 (05) : 330 - 339